These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7573590)

  • 1. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome.
    Nierenberg AA; McLean NE; Alpert JE; Worthington JJ; Rosenbaum JF; Fava M
    Am J Psychiatry; 1995 Oct; 152(10):1500-3. PubMed ID: 7573590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of onset of antidepressant response with fluoxetine treatment.
    Nierenberg AA; Farabaugh AH; Alpert JE; Gordon J; Worthington JJ; Rosenbaum JF; Fava M
    Am J Psychiatry; 2000 Sep; 157(9):1423-8. PubMed ID: 10964858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
    Reimherr FW; Amsterdam JD; Quitkin FM; Rosenbaum JF; Fava M; Zajecka J; Beasley CM; Michelson D; Roback P; Sundell K
    Am J Psychiatry; 1998 Sep; 155(9):1247-53. PubMed ID: 9734550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo.
    Tollefson GD; Holman SL
    Int Clin Psychopharmacol; 1994; 9(4):245-50. PubMed ID: 7868846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
    Fava M; Rappe SM; Pava JA; Nierenberg AA; Alpert JE; Rosenbaum JF
    J Clin Psychiatry; 1995 Feb; 56(2):52-5. PubMed ID: 7852252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor response to fluoxetine: underlying depression, serotonergic overstimulation, or a "therapeutic window"?
    Cain JW
    J Clin Psychiatry; 1992 Aug; 53(8):272-7. PubMed ID: 1500403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What constitutes an adequate antidepressant trial for fluoxetine?
    Schweizer E; Rickels K; Amsterdam JD; Fox I; Puzzuoli G; Weise C
    J Clin Psychiatry; 1990 Jan; 51(1):8-11. PubMed ID: 2403998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fixed-dose clinical trial of fluoxetine in outpatients with major depression.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1987 Oct; 48(10):406-8. PubMed ID: 3312176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citalopram treatment of fluoxetine nonresponders.
    Thase ME; Feighner JP; Lydiard RB
    J Clin Psychiatry; 2001 Sep; 62(9):683-7. PubMed ID: 11681763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.
    Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Michelson D; Hornig-Rohan M; Beasley CM
    Am J Psychiatry; 1997 Jul; 154(7):963-9. PubMed ID: 9210747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which depressed patients respond to nefazodone and when?
    Trivedi MH; Rush AJ; Pan JY; Carmody TJ
    J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.